GlaxoSmithKline has replaced the head of its China operations with one of its top two European managers, as the UK-based drugs company seeks to battle a widening corruption investigation.
葛兰素史克(GlaxoSmithKline, GSK)已更换其manbetx3.0 业务主管，新掌门人此前是该集团在欧洲的两名最高层经理之一。这家总部位于英国的制药商正忙于应对一场仍在扩大的腐败调查。
您已阅读7%（278字），剩余93%（3956字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。